Private equity and biotechnology: Michael Johnson talks about the role investors play in the development of the biotech industry
Michael Johnson, group head of institutional services at fund administrator Crestbridge, talks to Funds Europe about the role investors play in the development of the biotech industry. What due diligence must private equity funds carry out when investing in biotechnology? With a high degree of interest in biotechnology even before the pandemic hit, private funds […]
